XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.23.1

Merger with Sesen Bio (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Merger with Sesen Bio |
Schedule of net assets acquired in the Merger | ​
​ | ​ | ​ | ​
​ |  | March 7, 2023
Cash and cash equivalents | ​ | $ | 37,873
Marketable securities | ​ |  | 44,588
Prepaid expenses and other assets | ​ |  | 1,316
Restricted cash | ​ |  | 30
Accounts payable and accrued expenses | ​ |  | (3,499)
Total net assets acquired | ​ |  | 80,308
Less: Transaction costs | ​ |  | (8,264)
Total net assets acquired less transaction costs | ​ | $ | 72,044
​

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration